These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 11225322)

  • 1. [Influenza live attenuated vaccine].
    Kino Y
    Nihon Rinsho; 2000 Nov; 58(11):2307-12. PubMed ID: 11225322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety, efficacy and effectiveness of cold-adapted, live, attenuated, trivalent, intranasal influenza vaccine in adults and children.
    Belshe RB; Gruber WC
    Philos Trans R Soc Lond B Biol Sci; 2001 Dec; 356(1416):1947-51. PubMed ID: 11779396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Live attenuated versus inactivated influenza vaccine in infants and young children.
    Belshe RB; Edwards KM; Vesikari T; Black SV; Walker RE; Hultquist M; Kemble G; Connor EM;
    N Engl J Med; 2007 Feb; 356(7):685-96. PubMed ID: 17301299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trivalent live attenuated intranasal influenza vaccine administered during the 2003-2004 influenza type A (H3N2) outbreak provided immediate, direct, and indirect protection in children.
    Piedra PA; Gaglani MJ; Kozinetz CA; Herschler GB; Fewlass C; Harvey D; Zimmerman N; Glezen WP
    Pediatrics; 2007 Sep; 120(3):e553-64. PubMed ID: 17698577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness of live attenuated influenza vaccine versus inactivated influenza vaccine among children aged 24-59 months in the United States.
    Luce BR; Nichol KL; Belshe RB; Frick KD; Li SX; Boscoe A; Rousculp MD; Mahadevia PJ
    Vaccine; 2008 Jun; 26(23):2841-8. PubMed ID: 18462851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influenza vaccine response following its simultaneous application with BCG 1st report.
    Zykov MP; Raphaelskaya TI
    Z Erkr Atmungsorgane; 1981; 156(3):203-11. PubMed ID: 7293275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative efficacy of inactivated and live attenuated influenza vaccines.
    Monto AS; Ohmit SE; Petrie JG; Johnson E; Truscon R; Teich E; Rotthoff J; Boulton M; Victor JC
    N Engl J Med; 2009 Sep; 361(13):1260-7. PubMed ID: 19776407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of an influenza A H5N2 reassortant as a candidate for live-attenuated and inactivated vaccines against highly pathogenic H5N1 viruses with pandemic potential.
    Desheva JA; Lu XH; Rekstin AR; Rudenko LG; Swayne DE; Cox NJ; Katz JM; Klimov AI
    Vaccine; 2006 Nov; 24(47-48):6859-66. PubMed ID: 17050041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children.
    Belshe RB; Mendelman PM; Treanor J; King J; Gruber WC; Piedra P; Bernstein DI; Hayden FG; Kotloff K; Zangwill K; Iacuzio D; Wolff M
    N Engl J Med; 1998 May; 338(20):1405-12. PubMed ID: 9580647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety, efficacy, and effectiveness of cold-adapted influenza vaccine-trivalent against community-acquired, culture-confirmed influenza in young children attending day care.
    Vesikari T; Fleming DM; Aristegui JF; Vertruyen A; Ashkenazi S; Rappaport R; Skinner J; Saville MK; Gruber WC; Forrest BD;
    Pediatrics; 2006 Dec; 118(6):2298-312. PubMed ID: 17142512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pandemic H5N1 influenza vaccine development: an update.
    El Sahly HM; Keitel WA
    Expert Rev Vaccines; 2008 Mar; 7(2):241-7. PubMed ID: 18324892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cold-adapted, live attenuated influenza vaccine.
    Glezen WP
    Expert Rev Vaccines; 2004 Apr; 3(2):131-9. PubMed ID: 15056039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Recent progress in live influenza vaccine development].
    Kino Y
    Nihon Rinsho; 1997 Oct; 55(10):2746-50. PubMed ID: 9360401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Live attenuated influenza vaccine--a review.
    Gasparini R; Amicizia D; Lai PL; Panatto D
    J Prev Med Hyg; 2011 Sep; 52(3):95-101. PubMed ID: 22010534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and epidemiological evaluation of a live, cold-adapted influenza vaccine for 3-14-year-olds.
    Rudenko LG; Lonskaya NI; Klimov AI; Vasilieva RI; Ramirez A
    Bull World Health Organ; 1996; 74(1):77-84. PubMed ID: 8653819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of an attenuated H5N1 avian influenza virus vaccine with all eight genes from avian viruses.
    Shi H; Liu XF; Zhang X; Chen S; Sun L; Lu J
    Vaccine; 2007 Oct; 25(42):7379-84. PubMed ID: 17870216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety, immunogenicity and efficacy of intranasal, live attenuated influenza vaccine.
    Belshe R; Lee MS; Walker RE; Stoddard J; Mendelman PM
    Expert Rev Vaccines; 2004 Dec; 3(6):643-54. PubMed ID: 15606348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of live attenuated influenza vaccine in children: A meta-analysis of nine randomized clinical trials.
    Rhorer J; Ambrose CS; Dickinson S; Hamilton H; Oleka NA; Malinoski FJ; Wittes J
    Vaccine; 2009 Feb; 27(7):1101-10. PubMed ID: 19095024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of a single dose of live attenuated influenza vaccine in previously unvaccinated children: a post hoc analysis of three studies of children aged 2 to 6 years.
    Block SL; Toback SL; Yi T; Ambrose CS
    Clin Ther; 2009 Oct; 31(10):2140-7. PubMed ID: 19922885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The efficacy of live attenuated and inactivated influenza vaccines in children as a function of time postvaccination.
    Ambrose CS; Wu X; Belshe RB
    Pediatr Infect Dis J; 2010 Sep; 29(9):806-11. PubMed ID: 20458256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.